Colas Damien, Bezin Laurent, Gharib Abdallah, Morales Anne, Cespuglio Raymond, Sarda Nicole
Institut National de la Santé et de la Recherche Médicale EA3734, Department of Experimental Medicine, Faculty of Medecine, Claude Bernard University, Lyon Cedex 08 69373, France.
Neurobiol Aging. 2005 Nov-Dec;26(10):1375-84. doi: 10.1016/j.neurobiolaging.2004.11.002. Epub 2004 Dec 22.
Evidence that nitric oxide (NO) is involved in the regulation of rapid-eye-movement sleep (REMS) is supported by recent studies. During aging, NO generation encounters marked changes mainly related to the activation of the inducible NO-synthase (iNOS). To investigate links existing between iNOS and REMS impairments related to aging, we examine the age-related variations occurring in: mRNA and activity of iNOS in brainstem and frontal cortex; sleep parameters under baseline and after treatment by a selective iNOS inhibitor (AMT) in Senescence Accelerated Mice (SAM). SAMR1 (control) mice are a model of aging while SAMP8 are adequate to study neurodegenerative processes. RT-PCR analysis does not reveal significant variation in iNOS mRNA expression in both strains. However, significant age-related increases in iNOS activity occur in SAMR1 but such variation is not observed in SAMP8. In baseline conditions, aging induces a slight increase in slow-wave sleep (SWS) amounts in both groups and deteriorates greatly REMS architecture in SAMP8 compared to SAMR1. AMT reduces REMS amounts for 4-6h after treatment in a dose and age-dependent manner in SAMR1. Almost no changes occur in SAMP8. Data reported suggest that NO derived from iNOS contributes to trigger and maintain REMS during aging.
近期研究支持了一氧化氮(NO)参与快速眼动睡眠(REMS)调节的证据。在衰老过程中,NO的生成会发生显著变化,主要与诱导型一氧化氮合酶(iNOS)的激活有关。为了研究iNOS与衰老相关的REMS损伤之间存在的联系,我们研究了以下方面与年龄相关的变化:脑干和额叶皮质中iNOS的mRNA和活性;在衰老加速小鼠(SAM)中,基线状态下以及经选择性iNOS抑制剂(AMT)治疗后的睡眠参数。SAMR1(对照)小鼠是衰老模型,而SAMP8适合用于研究神经退行性过程。逆转录聚合酶链反应(RT-PCR)分析未显示两种品系中iNOS mRNA表达有显著差异。然而,SAMR1中iNOS活性出现了与年龄相关的显著增加,但在SAMP8中未观察到这种变化。在基线条件下,衰老导致两组慢波睡眠(SWS)量略有增加,与SAMR1相比,SAMP8的REMS结构严重恶化。在SAMR1中,AMT以剂量和年龄依赖性方式在治疗后4 - 6小时减少REMS量。SAMP8中几乎没有变化。报告的数据表明,衰老过程中iNOS衍生的NO有助于触发和维持REMS。